ABL Diagnostics, a Euronext-listed company specializing in molecular biology assays and software for microbiology laboratories, has announced the release of new versions of its CE-IVD DeepChek® and ViroScore® software applications. These web-based and highly secure downstream analysis platforms are tailored to analyze Next Generation Sequencing (NGS) and Capillary Electrophoresis (SANGER) data…
No responses yet